Berlin, February 20-23th 2019:
Defymed will participate to the 12th International ATTD 2019 (Advanced Technologies & Treatments for Diabetes) conference, taking place in Berlin, Germany. We will present main results obtained with MailPan® during an e-poster session. Do not hesitate to share with us your feedback regarding the poster named PRECLINICAL VALIDATION OF A CELL ENCAPSULATION DEVICE TO TREAT TYPE 1 DIABETES!
The conference on ATTD 2019 will present an outstanding scientific program delivered by renowned international experts. ATTD 2019 will showcase the latest developments in new insulin analogues and delivery systems, insulin pumps, glucose sensors, closed-loop systems, devices for diabetic prevention, artificial pancreas, new technologies for treating obesity and many more.
For more info